Diabetes and depression;Diabetes und depression

Deutsche Medizinische Wochenschrift

Volumn 130, Issue 17, 2005, Pages 1097-1102

  Regen, Francesca ^a   Merkl, A ^b   Heuser, I ^b   Dettling, M ^b   Anghelescu, I ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMISULPRIDE; AMITRIPTYLINE; ARIPIPRAZOLE; CARBAMAZEPINE; CLOMIPRAMINE; CLOZAPINE; DESIPRAMINE; DOSULEPIN; DOXEPIN; DULOXETINE; GABAPENTIN; HEMOGLOBIN A1C; LAMOTRIGINE; LITHIUM; MIANSERIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; PREGABALIN; QUETIAPINE; REBOXETINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE; ANTIDEPRESSANT AGENT;

DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCOSE TRANSPORT; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; MAJOR DEPRESSION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY OF LIFE; REVIEW; PREVALENCE; PSYCHOLOGICAL ASPECT; RISK FACTOR;

ANTIDEPRESSIVE AGENTS; DEPRESSION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; HUMANS; PREVALENCE; RISK FACTORS;

EID: 18744378564     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-866794     Document Type: Review

References (52)

1. Agelink MW, Baumann B, Sanner D, Kavuk I, Mueck-Weymann M. Komorbidät zwischen kardiovaskulären Erkrankungen and Depressionen. Dtsch Med Wochenschr 2004; 129: 697-700
2. American Diabetes Association; American Psychiatrie Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27: 596-601
3. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24: 1069-1078
4. Bech P, Gudex C, Johansen KS. The WHO (Ten) Well-Being Index: validation in diabetes. Psychother Psychosom 1996; 65: 183-190
5. Chen JL, Spinowitz N, Karwa M. Hypertriglyceridemia, acute pancreatitis, and diabetic ketoacidosis possibly associated with mirtazapine therapy: a case report. Pharmacotherapy 2003; 23: 940-944
6. Ciechanpwski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160: 3278-3285
7. Clouse RE, Lustman PJ, Freedland KE, Griffith LS, McGill JB, Carney RM. Depression and coronary heart disease in women with diabetes. Psychosom Med 2003; 65: 376-383
8. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001; 63: 619-630
9. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-2107
10. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996; 19: 1097-1102
11. Egede LE, Zheng D. Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care 2003; 26: 104-111
12. Egede LE. Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 2004; 27: 421-428
13. Egede LE. Effects of depression on work loss and disability bed days in individuals with diabetes. Diabetes Care 2004; 27: 1751-1753
14. Finkelstein EA, Bray JW, Chen H, Larson MJ, Miller K, Tompkins C, Keme A, Manderscheid R. Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care 2003; 26: 415-420
15. Fortner MR, Brown K, Varia IM, Gersing KR, O'Connor C, Doraiswamy PM. Effect of Bupropion SR on the quality of life of elderly depressed patients with comorbid medical disorders. J Clin Psychiatry 1999; 1: 174-179
16. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83: 847-850
17. Gary TL, Crum RM, Cooper-Patrick L, Ford D, Brancati FL. Depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care 2000; 23: 23-29
18. Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care 1993; 16: 1167-1178
19. Ghaeli P, Shahsavand E, Mesbahi M, Kamkar MZ, Sadeghi M, Dashti-Khavidaki S. Comparing the effects of 8-week treatment with fluoxetine and imipramine on fasting blood glucose of patients with major depressive disorder. J Clin Psychopharmacol 2004; 24: 386-388
20. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J. Smoking, smoking cessation, and major depression. J Am Med Assoc 1990; 264: 1546-1549
21. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Jr. Bigger JT, Krishnan KR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, Barton D, McIvor M Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. J Am Med Assoc 2002; 288: 701-709
22. Golden SH, Williams JE, Ford DE, Yeh HC, Paton Sanford C, Nieto FJ, Brancati FL Atherosclerosis risk in communities study. Depressive symptoms and the risk of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2004; 27: 429-435
23. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life: a population study. Diabetes Care 2004; 27: 1066-1070
24. Goodman E, Whitaker RC. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 2002; 110: 497-504
25. Henkel V, Mergl R, Coyne JC, Kohnen R, Moller HJ, Hegerl U. Screening for depression in primary care: will one or two items suffice? Eur Arch Psychiatry Clin Neurosci 2004; 254: 215-223
26. Iosifescu DV, Bankier B, Fava M. Impact of medical comorbid disease on antidepressant treatment of major depressive disorder. Current Psychiatry Reports 2004; 6: 193-201
27. Katon W, von Korff M, Ciechanowski P, Russo J, Lin E, Simon G, Ludman E, Walker E, Bush T, Young B. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 2004; 27: 914-920
28. Katon WJ, Lin EH, Russo J, Von Korff M, Ciechanowski P, Simon G, Ludman E, Bush T, Young B. Cardiac risk factors in patients with diabetes mellitus and major depression. J Gen Intern Med 2004; 19: 1192-1199
29. Katon WJ, Von Korff M, Lin EH, Simon G, Ludman E, Russo J, Ciechanowski P, Walker E, Bush T. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004; 61: 1042-1049
30. Kawakami N, Takatsuka N, Shimizu H, Ishibashi H. Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 1999; 22: 1071-1076
31. Kent S, Bluthe RM, Kelley KW, Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci 1992; 13: 24-28
32. Kompetenznetz "Depression"; http://www.kompetenznetz- depression.de.
33. Ludman EJ, Katon W, Russo J, Von Korff M, Simon G, Ciechanowski P, Lin E, Bush T, Walker E, Young B. Depression and diabetes symptom burden. Gen Hosp Psychiatry 2004; 26: 430-436
34. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000; 23: 934-942
35. Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE. Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med 1997; 59: 24-31
36. Lustman PJ, Freedland KE, Carney RM, Hong BA, Clouse RE. Similarity of depression in diabetic and psychiatric patients. Psychosom Med 1992; 54: 602-611
37. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997; 59: 241-250
38. Lustman PJ, Griffith LS, Freedland KE, Clouse RE. The course of major depression in diabetes. Gen Hosp Psychiatry 1997; 19: 138-143
39. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1998; 12: 613-621
40. Lustman PJ, Harper GW. Nonpsychiatric physicians' identification and treatment of depression in patients with diabetes. Compr Psychiatry 1987; 28: 22-27
41. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002; 90: 1279-1283
42. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003; 54: 317-329
43. Musselman DL, DiBattista C, Nathan KI, Kilts CD, Schatzberg AF, Nemeroff CB. Biology of mood disorders. 2nd ed (Hrsg). Washington, DC:APA Press, In: Schatzberg AF, Nemeroff CB, editors. American Psychiatric Textbook of Psychopharmacology. 1998: 550-588
44. Newcomer JW, Haupt DW, Fucetola R, Melson AK, Schweiger JA, Cooper BP, Selke G. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 2002; 59: 337-345
45. Niedermaier N, Bohrer E, Schulte K, Schlattmann P, Heuser I. Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke. J Clin Psychiatry 2004; 65: 1619-1623
46. Ormel J, Rijsdijk FV, Sullivan M, van Sonderen E, Kempen GI. Temporal and reciprocal relationship between IADL/ADL disability and depressive symptoms in late life. J Gerontol B Psychol Sci Soc Sci 2002; 57: 338-347
47. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126
48. Schindler F, Anghelescu I. HAMD-Subskalen: schneller und besser als die Langversion? Neurotransmitter 2004; 15: 56-58
49. Weber-Hamann B, Hentschel F, Kniest A, Deuschle M, Colla M, Lederbogen F, Heuser I. Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom Med 2002; 64: 274-277
50. Weyerer S, Hewer W, Pfeifer-Kurda M, Dilling H. Psychiatric disorders and diabetes - results from a community study. J Psychosom Res 1989; 33: 633-640
51. Jr. Williams JW, Katon W, Lin EH, Noel PH, Worchel J, Cornell J, Harpole L, Fultz BA, Hunkeler E, Mika VS, Unutzer J IMPACT Investigators. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004; 140: 1015-1024
52. Wilson WH, Bigelow DA. The effect of hypertension and obesity on the development of diabetes mellitus in patients treated with atypical anti-psychotic drugs. J clin Psychopharmacol 2004; 24: 452-454